Meeting Coverage
EULAR
European Alliance of Associations for Rheumatology
Latest EULAR Meeting Coverage
Early phase III data cement case for novel IL-17A inhibitor
New treatment options on the horizon come into better focus
Improvement in pain and function lasted well after formal program ended
The name says it all, but progress appears to be coming
Numbers of patients, length of follow-up keep growing with no visible downside (yet)
Novel agent adds additional action in hopes of improving efficacy
Phase III results back potential competitor for pegloticase-methotrexate treatment
Of three major prognostic tools, none hit the mark
New study finds marked risk reduction tied to drugs' urate-lowering effect
Stunning improvement for two patients with rare form of autoimmune myositis
Familiar biologic halts progression in high-risk patients with just a few painful joints
In separate studies, one old standby and one newer biologic appeared helpful
Latest indication for deucravacitinib seen as approvable for multiple rheumatologic conditions
Latest Rheumatology Meeting Coverage
-
EULAR: European Alliance of Associations for Rheumatology
June 2024
-
ACR: American College of Rheumatology
November 2023
-
BSR: British Society for Rheumatology
April 2020
-
ACR-SOTA: ACR State-of-the-Art Clinical Symposium
March 2020